Cannabis & Hemp Taxation & Incentives in Colombia

Colombia has built one of the most commercially accessible legal cannabis and hemp frameworks in Latin America, yet the tax and incentive architecture governing the sector remains poorly understood by most foreign investors. Operators face a layered system of national corporate taxes, industry-specific levies, VAT treatment that varies by product category, and a set of incentives - including free trade zone benefits and research deductions - that can materially reduce the effective tax burden. Getting the structure right from the outset determines whether a cannabis or hemp operation in Colombia is economically viable or chronically loss-making.

This article covers the legal basis for cannabis and hemp taxation in Colombia, the incentives available to licensed operators, the most common compliance failures by international entrants, and the strategic choices that determine long-term fiscal efficiency.

Colombia';s cannabis sector is governed primarily by Law 1787 of 2016 (Ley 1787 de 2016), which legalised the cultivation, production, and export of cannabis for medicinal and scientific purposes. Decree 613 of 2017 (Decreto 613 de 2017) operationalised the licensing regime administered by the Ministry of Justice and Law (Ministerio de Justicia y del Derecho) and the Ministry of Health and Social Protection (Ministerio de Salud y Protección Social). Hemp - defined in Colombian regulation as cannabis plants with a THC concentration at or below 1% - is regulated separately under Decree 811 of 2021 (Decreto 811 de 2021), which opened industrial hemp cultivation and processing to a broader class of operators.

For tax purposes, the Colombian Tax Authority (Dirección de Impuestos y Aduanas Nacionales, DIAN) does not treat cannabis or hemp as a single product category. Classification depends on the form of the product: raw plant material, seeds, psychoactive cannabis derivatives, non-psychoactive derivatives, and finished pharmaceutical or cosmetic products each attract different treatment under the Tax Statute (Estatuto Tributario). This classification directly affects VAT applicability, income tax deductibility of costs, and eligibility for special regimes.

A common mistake made by international operators is to assume that because cannabis is "legal" in Colombia, it is treated uniformly for tax purposes. In practice, the same company may hold multiple product lines that fall under different tax categories simultaneously, requiring separate accounting streams and separate VAT treatment. Failure to maintain this separation from the start creates significant rectification costs later.

The National Food and Drug Surveillance Institute (Instituto Nacional de Vigilancia de Medicamentos y Alimentos, INVIMA) plays a regulatory role that intersects with tax classification: products that obtain INVIMA sanitary registration as pharmaceutical goods receive different VAT treatment than those sold as raw agricultural commodities or cosmetic inputs.

Colombian corporate income tax (impuesto sobre la renta) applies to cannabis and hemp companies at the general rate of 35% on net taxable income, as established under Article 240 of the Tax Statute. This rate applies to both domestic companies and foreign entities with a permanent establishment in Colombia. There is no reduced rate specifically for cannabis or hemp operators at the national level, which distinguishes Colombia from jurisdictions that have created preferential corporate tax regimes for the sector.

However, several deductions available under the general Tax Statute are particularly relevant to cannabis and hemp businesses:

• Research and development (R&D) deductions under Article 158-1 of the Tax Statute allow companies to deduct 100% of investments in science, technology, and innovation projects certified by Minciencias (Ministry of Science, Technology and Innovation). Cannabis and hemp companies engaged in genetic research, agronomic development, or pharmaceutical formulation regularly qualify.
• Investments in fixed productive assets located in certain regions may attract an additional deduction under Article 158-3 of the Tax Statute, subject to conditions.
• Environmental investments certified by the relevant environmental authority (Corporación Autónoma Regional) may generate deductions under Article 255 of the Tax Statute.
• Losses may be carried forward indefinitely under Article 147 of the Tax Statute, which is commercially significant given that most cannabis and hemp operations run at a loss during the first two to four years of operation.

In practice, it is important to consider that DIAN scrutinises cost deductions in the cannabis sector more closely than in conventional agriculture. The agency has challenged deductions where companies could not demonstrate a direct causal link between the expenditure and the licensed activity. Operators should maintain detailed cost allocation records segmented by licensed activity from the first fiscal year.

A non-obvious risk is the treatment of licence fees paid to the Ministry of Justice and Health. These fees - which can be substantial for large-scale cultivation or seed use licences - are generally deductible as ordinary business expenses, but only if the licence is directly connected to the income-generating activity. Where a company holds licences for activities not yet generating revenue, the deductibility of associated fees may be deferred.

To receive a checklist on corporate income tax deductions for cannabis and hemp operators in Colombia, send a request to info@vlolawfirm.com

Value added tax (impuesto sobre las ventas, IVA) treatment is one of the most commercially consequential and frequently misunderstood areas of cannabis and hemp taxation in Colombia. The general VAT rate is 19% under Article 468 of the Tax Statute. However, several exemptions and exclusions apply depending on the product and its destination.

Raw agricultural products, including unprocessed cannabis plant material and hemp biomass, are excluded from VAT under Article 424 of the Tax Statute, which lists agricultural goods not subject to the tax. This exclusion applies to domestic sales of raw material between producers and processors. Importantly, an exclusion means no VAT is charged and no input VAT credit is generated - a distinction that affects the economics of vertically integrated operations.

Pharmaceutical products derived from cannabis that obtain INVIMA registration as medicines are exempt from VAT under Article 477 of the Tax Statute. An exemption, unlike an exclusion, allows the seller to recover input VAT paid on inputs used to produce the exempt good. This makes the pharmaceutical pathway fiscally more attractive for vertically integrated operators than the cosmetic or food supplement pathway, where products are typically taxed at 19%.

Hemp-derived products sold as cosmetics, food supplements, or industrial inputs are generally subject to VAT at 19%. Operators exporting these products benefit from the zero-rate export regime under Article 481 of the Tax Statute, which allows recovery of all input VAT associated with exported goods through the DIAN refund mechanism.

A common mistake is to conflate the exclusion and exemption categories. An operator selling raw hemp biomass domestically (excluded) cannot recover input VAT on seeds, fertilisers, or equipment used in production. An operator exporting finished hemp extract (zero-rated) can recover all input VAT. This asymmetry means that the choice between domestic and export sales channels has a direct fiscal cost implication that must be modelled before the business structure is finalised.

The VAT refund process for exporters in Colombia is administered by DIAN and typically takes between 30 and 90 days from the filing of a complete refund request. Delays are common where documentation is incomplete or where the company has open tax audits. Operators should budget for working capital requirements to cover this gap.

Colombia offers several incentive mechanisms that cannabis and hemp operators can access, subject to meeting specific conditions. These are not sector-specific subsidies but general investment promotion tools that the cannabis and hemp sector can use effectively.

Free trade zones (zonas francas)

The free trade zone regime under Law 1004 of 2005 (Ley 1004 de 2005) and its implementing regulations offers a reduced corporate income tax rate of 20% (compared to the general 35%) for companies operating within a declared free trade zone. Cannabis and hemp processing and manufacturing operations - particularly those oriented toward export - can qualify for single-enterprise free trade zone status (zona franca permanente especial) if they meet the minimum investment and job creation thresholds set by the Ministry of Commerce, Industry and Tourism (Ministerio de Comercio, Industria y Turismo).

The free trade zone regime also provides customs benefits: inputs, machinery, and equipment imported into the zone are not subject to import duties or VAT at the time of entry. This is commercially significant for cannabis and hemp operators that rely on imported extraction equipment, laboratory instruments, or packaging materials. The effective saving on a mid-scale extraction facility can reach the low hundreds of thousands of USD in deferred or eliminated import costs.

A non-obvious risk is that free trade zone status imposes strict operational requirements. Goods produced within the zone and sold into the Colombian domestic market are treated as imports and subject to full customs duties and VAT. Operators whose business model includes both export and domestic sales must carefully model the split to determine whether free trade zone status is net beneficial.

Megainvestment regime (régimen de mega-inversiones)

Law 2010 of 2019 (Ley 2010 de 2019) introduced the megainvestment regime for companies committing to invest at least 30,000 UVT (Unidad de Valor Tributario, the Colombian tax unit adjusted annually) in productive assets over a five-year period and creating at least 400 new jobs. Qualifying companies pay corporate income tax at a fixed rate of 27% and are exempt from the equity surcharge (sobretasa). Large-scale cannabis and hemp operations - particularly integrated cultivation, extraction, and manufacturing facilities - may reach the investment threshold, though the job creation requirement is demanding for capital-intensive operations.

R&D tax credits and Minciencias certification

The R&D deduction under Article 158-1 of the Tax Statute, mentioned above, is the most accessible incentive for early-stage cannabis and hemp operators. Minciencias certification of a research project is required, but the process is manageable for companies with documented research programmes. The deduction covers not only internal R&D costs but also payments to certified research institutions and universities, which creates a pathway for companies to partner with Colombian universities - several of which have active cannabis and hemp research programmes - and generate deductible expenditure simultaneously.

Departmental and municipal incentives

Several Colombian departments (departamentos) - including Cauca, Tolima, and Cundinamarca - have offered industry tax incentives at the sub-national level, including temporary reductions in the industry and commerce tax (impuesto de industria y comercio, ICA) for cannabis and hemp operators establishing facilities in their territories. These incentives are not uniform and require direct negotiation with the relevant departmental or municipal authority. They are also subject to change and should not be relied upon as a permanent structural element of the business model.

To receive a checklist on available tax incentives and free trade zone eligibility for cannabis and hemp operators in Colombia, send a request to info@vlolawfirm.com

Understanding the rules in the abstract is insufficient. The following three scenarios illustrate how the tax and incentive framework applies in practice to different types of operators.

Scenario 1: Foreign investor establishing a cultivation and export operation

A European company establishes a Colombian subsidiary to cultivate psychoactive cannabis under a cultivation licence and export dried flower and crude extract to regulated markets in Europe. The subsidiary is subject to Colombian corporate income tax at 35% on net income. Because substantially all sales are exports, the subsidiary benefits from zero-rated VAT on its output and can recover input VAT on seeds, fertilisers, irrigation equipment, and processing inputs through DIAN refunds. The company applies for Minciencias certification of its genetic selection programme, generating an R&D deduction that reduces taxable income in the first three years. If the investment volume is sufficient, the company evaluates single-enterprise free trade zone status to reduce the corporate rate to 20% and eliminate import duties on extraction equipment. The key risk is that DIAN challenges the R&D deduction if the research programme is not sufficiently documented and distinct from routine cultivation activities.

Scenario 2: Domestic processor selling hemp-derived cosmetics in Colombia

A Colombian company processes industrial hemp biomass purchased from licensed cultivators and sells hemp-derived cosmetic products domestically. The company pays 19% VAT on its cosmetic sales and cannot recover input VAT on the raw hemp biomass it purchases (which is VAT-excluded at the agricultural stage). The effective VAT cost embedded in the supply chain reduces margins. The company considers restructuring to include an export component, which would allow it to zero-rate a portion of sales and recover the corresponding input VAT. The ICA tax applies to the company';s gross revenue at rates set by the relevant municipality, typically between 0.2% and 1.4% of gross income. The company explores whether its product development activities qualify for Minciencias R&D certification to generate income tax deductions.

Scenario 3: Pharmaceutical manufacturer seeking INVIMA registration

An international pharmaceutical group establishes a Colombian manufacturing subsidiary to produce cannabis-derived pharmaceutical products for domestic sale and export. Products with INVIMA pharmaceutical registration are VAT-exempt on domestic sales, allowing the company to recover input VAT on all production inputs. The company structures its Colombian operation within a single-enterprise free trade zone to benefit from the 20% corporate rate and duty-free importation of active pharmaceutical ingredients and packaging. The company must demonstrate to DIAN that transfer pricing between the Colombian subsidiary and its foreign parent - particularly for intellectual property licences and management fees - complies with the arm';s length standard under Article 260-3 of the Tax Statute. Transfer pricing documentation is mandatory for transactions with related parties abroad and must be filed annually with DIAN.

DIAN has progressively increased its audit activity in the cannabis and hemp sector as the industry has matured. The agency';s focus areas include cost deduction substantiation, VAT classification of products, and transfer pricing compliance for companies with foreign related parties.

Transfer pricing

Transfer pricing is the single most significant compliance risk for international cannabis and hemp groups operating in Colombia. Under Articles 260-1 through 260-11 of the Tax Statute, transactions between a Colombian entity and its foreign related parties must be conducted at arm';s length prices. This applies to sales of cannabis or hemp products to related foreign distributors, royalty payments for intellectual property (including proprietary genetics or extraction technology), management fee payments, and intercompany loans.

Many international cannabis groups underappreciate the complexity of benchmarking cannabis and hemp transactions. Because comparable market data for cannabis products is limited - given that the product is not traded on open commodity markets - companies must construct internal comparables or use profit-based methods. DIAN has challenged transfer pricing positions where companies could not produce adequate documentation. Penalties for transfer pricing non-compliance can reach 15% of the value of the non-documented transaction, with additional interest charges.

Substance requirements and permanent establishment risk

A non-obvious risk for foreign investors using Colombian subsidiaries is the permanent establishment (establecimiento permanente) analysis under Article 20-1 of the Tax Statute. Where a foreign parent exercises operational control over the Colombian subsidiary - for example, by directing cultivation decisions, approving sales contracts, or managing employees directly - DIAN may assert that the foreign parent has a permanent establishment in Colombia and is subject to Colombian income tax on profits attributable to that establishment. This risk is particularly acute for foreign groups that maintain tight operational control over their Colombian operations for quality or regulatory reasons.

Licence fee deductibility and DIAN scrutiny

Licence fees paid to the Ministry of Justice and Health are deductible in principle, but DIAN has questioned deductions where the licence covers activities not yet generating taxable income. The agency applies the causality principle (principio de causalidad) under Article 107 of the Tax Statute, which requires that deductible expenses be necessary and proportionate to the income-generating activity. Operators should document the operational nexus between each licence and the corresponding revenue stream.

Municipal ICA tax

The industry and commerce tax (ICA) is levied by municipalities on gross revenue from industrial, commercial, and service activities. Cannabis and hemp operators are subject to ICA in each municipality where they conduct activities. The applicable rate varies by municipality and by the classification of the activity. Operators with cultivation sites, processing facilities, and commercial offices in different municipalities must register and file ICA returns in each jurisdiction separately. A common mistake is to file ICA only in the municipality of the registered office, omitting municipalities where physical operations occur.

What is the most significant tax risk for a foreign company entering the Colombian cannabis market?

Transfer pricing is consistently the highest-risk area for foreign-owned cannabis and hemp operations in Colombia. Transactions between a Colombian subsidiary and its foreign parent - including product sales, IP licences, and management fees - must comply with the arm';s length standard and be supported by annual transfer pricing documentation filed with DIAN. The cannabis sector presents particular challenges because comparable market data is scarce, making it difficult to benchmark prices using standard methods. Companies that enter Colombia without a transfer pricing policy in place from the first year of operations often face significant retrospective adjustments and penalties. Engaging a transfer pricing specialist before the first intercompany transaction is executed is a practical necessity, not an optional step.

How long does it take to obtain free trade zone status, and what does it cost?

The process for obtaining single-enterprise free trade zone (zona franca permanente especial) status in Colombia typically takes between six and eighteen months from the submission of a complete application to the Ministry of Commerce, Industry and Tourism. The process involves a feasibility study, a formal application, ministerial evaluation, and a presidential decree of declaration. Professional and advisory costs for the application process generally start from the low tens of thousands of USD. The investment and job creation thresholds are the primary qualification hurdles: the minimum investment requirement is set in UVT and adjusted annually, and the job creation requirement (currently 500 direct jobs for new zones, with lower thresholds for certain categories) must be met within the declared timeline. Companies that do not meet these thresholds within the agreed period risk losing zone status and facing retroactive tax assessments.

Is it better to structure a Colombian cannabis operation as a branch or a subsidiary?

For most international cannabis and hemp investors, a Colombian subsidiary (sociedad por acciones simplificada, SAS, or sociedad anónima, SA) is preferable to a branch (sucursal) for both tax and operational reasons. A subsidiary is a separate legal entity, which limits the parent';s liability exposure and simplifies transfer pricing documentation. A branch is treated as an extension of the foreign parent and is subject to Colombian income tax on profits attributable to the branch, with an additional remittance tax (impuesto de remesas) on profits transferred abroad under Article 321 of the Tax Statute. The subsidiary structure also allows the Colombian entity to access free trade zone status and Minciencias R&D certification independently. The branch structure may be appropriate for short-term project activities but is generally not recommended as the permanent vehicle for a cannabis or hemp operation.

Colombia';s cannabis and hemp tax framework rewards operators who invest in structural planning before commencing operations. The combination of general corporate income tax at 35%, VAT rules that vary sharply by product category and sales channel, and available incentives - including free trade zone rates, R&D deductions, and export zero-rating - means that two companies with identical revenues can have materially different effective tax burdens depending on how their operations are structured. The compliance risks, particularly in transfer pricing and VAT classification, are real and have resulted in significant assessments against operators who treated tax as an afterthought. Early engagement with the Colombian tax framework is not a cost - it is a condition for sustainable operations.

To receive a checklist on tax structuring and compliance priorities for cannabis and hemp operators in Colombia, send a request to info@vlolawfirm.com

Our law firm VLO Law Firms has experience supporting clients in Colombia on cannabis and hemp taxation, licensing, and compliance matters. We can assist with corporate structuring, free trade zone applications, transfer pricing documentation, VAT classification analysis, and DIAN audit defence. To receive a consultation, contact: info@vlolawfirm.com